Tenderwize
Retour à la recherche

Non-exclusive Discount Agreement for Sevofluran (Open-House)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Apr 27, 2028 · 614 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Sevofluran (ATC-Code: N01AB08).

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No procurement documents were analyzed; required documents and exact conditions unknown.

No estimated value or volume data provided; financial potential is unclear.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Sevofluran (ATC N01AB08) as finished medicinal products for office supply in Lower Saxony
  • Provision of discount agreements under §130a Abs. 8 SGB V
Afficher le résumé complet

Non-exclusive discount agreement (open-house model) for the active substance Sevofluran (ATC N01AB08) for office supply needs in Lower Saxony, Germany. The contract runs from 01.07.2026 to 30.06.2028, with rolling enrollment. All interested pharmaceutical entrepreneurs meeting eligibility can join under uniform, non-negotiable conditions. No selection decision is made by the buyer.

Risques

No procurement documents were analyzed; required documents and exact conditions unknown.

No estimated value or volume data provided; financial potential is unclear.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs. 18 AMG
  • Must have establishment in EU/EEA (AMG §9 Abs. 2)
  • Products must be approved for the German market

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria; no selection process.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive Discount Agreement for Sevofluran (Open-House)

Open-house model for Sevofluran (ATC N01AB08) for office supply in Lower Saxony. No selection; uniform conditions for all participants. Contracts last up to 24 months, ending 30.06.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Jun 2026 - Jun 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria; no selection process.

Date limite

Deadline Apr 27, 2028

Détails de la procédure

Date de publication
14 May 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
334218-2026

Appels d'offres similaires